| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
167 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
853 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
265 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
741 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
864 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6858599 |
Tricyclic compound having spiro union |
Feb. 22, 2005 |
| 6858600 |
Proteomimetic compounds and methods |
Feb. 22, 2005 |
| 6858601 |
Parasiticidal formulation for animals |
Feb. 22, 2005 |
| 6858602 |
Compounds for the treatment of metabolic disorders |
Feb. 22, 2005 |
| 6858624 |
Aryl fused azapolycyclic compounds |
Feb. 22, 2005 |
| 6855705 |
11-O-methylgeldanamycin compounds |
Feb. 15, 2005 |
| 6855735 |
Ketamine treatment of restless legs syndrome |
Feb. 15, 2005 |
| 6852711 |
HIV protease inhibitors |
Feb. 8, 2005 |
| 6852712 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
Feb. 8, 2005 |
| 6849617 |
Tissue factor antagonists and methods of use thereof |
Feb. 1, 2005 |
| 6849618 |
Uracil substituted phenyl sulfamoly carboxamides |
Feb. 1, 2005 |
| 6849619 |
Substituted pyridoindoles as serotonin agonists and antagonists |
Feb. 1, 2005 |
| 6846807 |
Colorectal neoplasia prophylaxis |
Jan. 25, 2005 |
| 6846813 |
Compounds to treat alzheimer's disease |
Jan. 25, 2005 |
| 6846814 |
Neurokinin antagonists for use as medicaments |
Jan. 25, 2005 |
| 6846815 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
Jan. 25, 2005 |
| 6841530 |
Semi-synthetic studies toward didemnin analogues |
Jan. 11, 2005 |
| 6841549 |
Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
Jan. 11, 2005 |
| 6838453 |
Antagonist derivatives of the vitronectin receptor |
Jan. 4, 2005 |
| 6838454 |
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
Jan. 4, 2005 |
| 6835725 |
Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
Dec. 28, 2004 |
| 6835726 |
Pyrimidine derivatives |
Dec. 28, 2004 |
| 6833366 |
Dihydrostilbene alkanoic acid derivatives |
Dec. 21, 2004 |
| 6831074 |
Pharmaceutically active compounds |
Dec. 14, 2004 |
| 6831075 |
Heterocyclic substituted pyrazolones |
Dec. 14, 2004 |
| 6831076 |
Epothilons C and D, preparation and compositions |
Dec. 14, 2004 |
| 6825183 |
Substituted benzoylcyclohexanediones for use as herbicides |
Nov. 30, 2004 |
| 6825184 |
1,4-Disubstituted benzo-fused urea compounds |
Nov. 30, 2004 |
| 6825185 |
Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
Nov. 30, 2004 |
| 6821962 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases |
Nov. 23, 2004 |
| 6818637 |
Polyhydroxypyrazine derivatives, their preparation and the pharmaceutical compositions which comprise them |
Nov. 16, 2004 |
| 6818638 |
Melvinolin derivatives |
Nov. 16, 2004 |
| 6818670 |
Active ingredient combination having insecticidal and acaricidal characteristics |
Nov. 16, 2004 |
| 6815437 |
Streptogramines, their preparation and compositions containing them |
Nov. 9, 2004 |
| 6815438 |
Heteroaryl-diazabicycloalkanes |
Nov. 9, 2004 |
| 6815439 |
Substituted aza-oxindole derivatives |
Nov. 9, 2004 |
| 6812225 |
Therapeutic heterocyclic compounds |
Nov. 2, 2004 |
| 6812226 |
P2X7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disease |
Nov. 2, 2004 |
| 6812227 |
Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
Nov. 2, 2004 |
| 6809088 |
Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
Oct. 26, 2004 |
| 6809089 |
Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
Oct. 26, 2004 |
| 6809090 |
Derivatives of N-(iminomethy)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
Oct. 26, 2004 |
| 6806264 |
Arylphenyl-substituted cyclic ketoenols |
Oct. 19, 2004 |
| 6803362 |
Heterocyclic compounds |
Oct. 12, 2004 |
| 6800618 |
Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof |
Oct. 5, 2004 |
| 6800619 |
Caspase inhibitors and uses thereof |
Oct. 5, 2004 |
| 6800620 |
Inhibitors of human phosphatidylinositol 3-kinase delta |
Oct. 5, 2004 |
| 6797706 |
Heterocyclecarboxamide derivative |
Sep. 28, 2004 |
| 6797707 |
Antagonists of RF-amide neuropeptides |
Sep. 28, 2004 |
| 6797721 |
Phorboxazole derivatives for treating cancer |
Sep. 28, 2004 |
|
|
|
